In glioblastoma, curcumin inhibits the formation of VM in human glioma U251 cells in a dose-dependent manner by down-regulating the protein and mRNA expression of EphA2, PI3K, and MMPs [38]. Here, EPHA2 is linked to central nervous system cancer.